michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, very fair question. We talk a lot about this, right? It's particularly a bandwidth question around the financial integration. Many times, we're buying family businesses that aren't up to the sophistication that we are. We've been able to put in external resources, internal resources.
We've been hiring and adding things there. We aren't going to keep the pace of one a month. I'll promise you that. That's a bit aggressive.
But also you can't time M&A when it becomes available, right? And we want to become aggressive, but not overly aggressive to do things. So you can expect us to stay on this track to doing more and more and more. But yes, I think that the one-a-month pace is a little quick. And we've been able to absorb it so far and getting everything filed on time and feeling comfortable that we've got the right informations and numbers.
But it will slow some, but we're still going to become an acquirer of choice and a person that rolls up this business and rolls up this industry, hopefully quite successfully.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, sure. So what's included the biggest change that's included in unallocated is the CARES Act grant income. So we received that money and then as we pay qualifying non-executive US salaries, wages and benefits, then we record the grant income in unallocated. So when you're looking on a period-over-period basis, that's the item that will stand out.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thank you. Good morning. Beth, my question is for you around the iOS privacy changes.
A lot of DTC brands have seen challenges over the last six months. Can you just drill down on that topic? How are you navigating this for Brilliant Earth? And then have you seen any erosion in advertising metrics thus far as a result?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Nik.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So we still feel pretty good about our labor position. I mean we've struggled like everyone else in terms of getting new applicants in the door for sure during the period of time where there was a lot of federal-state money floating around and now that that's over most everywhere, hopefully that trend starts to change and we can get a continual supply of people coming through the front door. We, from a retention and productivity perspective, we still feel good. We're clearly in a position to be able to kind of continue to do what we've been doing as it relates to market opportunity and in turnover again remains, we believe, quite a bit below industry averages. So it's still in our favor.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So I think, look, we've been very proactive in terms of pulling back on promotions through the year. Is there further room? I would say some, but not significant, right? And I would say those are particularly in maybe some of the Asian markets. We've got a little bit of opportunity to continue to pull back as the brand heat starts to accelerate in those markets.
But I don't think that's significant going forward. We've done a lot. If you look at our U.S. website, I mean, it's essentially been nonpromotional all year long, etc.
And I think -- and as you look at our stores, also essentially nonpromotional. If you talk about price increases, yes, there are some price increases that we're planning in '22. Those have already been communicated. I would say they are stronger outside of the U.S., particularly in EMEA and, again, in Asia as we look to manage price value in given markets.
As we said, we always look at the price of the product relative to competition, relative to the brand heat in that particular market. So there are some price increases that will flow through in '22. But I would say they are also dramatically less significant than the moves that we made this year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Rich, it's Kevin. I guess, I would tell you, it's a little bit of both. It's geography and it's asset type. We've definitely seen the more need-driven components come back sooner. People have been quarantine now for over a year and they're now that they're able to access the vaccine they have a little more confidence. This is what we've been talking about in prior conference calls of helping that consumer confidence and being able to make a purchasing decision. So we've seen that need-driven component definitely rebound a little bit faster. As we talked about in the prepared remarks, with specific to Holiday, we actually have seen small positive months for the last two months now which is a good sign, but it's been slower to come back than what we've seen with Bickford, for example. And then, within that, there are still some geographies where they had just started to discuss or loosen up some of their touring and restrictions just by way of example, we had some communities in Oregon that went back to full lockdown, a week ago, two weeks ago. So there are pockets across the nation, where dependent on local authorities it makes it very hard for them to do business and get move-ins and tours and do their traditional jobs. So unfortunately, it's a little bit of both. By and large, our communities are open for business and able to tour prospective residents, and have family visitors, which is -- was the big things that we needed. But unfortunately, it still does persist in some areas.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I mean, everybody sits in these seats like Pete and I, and everybody is doing these calls in the E&C industry are sitting here thinking the same thing. And we're getting our crystal ball out. We're trying to what's going to be transitory out of these inflationary and supply chain effects and what's going to be a new normal. We hope that most of it will return to normal.
But obviously, some of the escalations, particularly in labor, will continue. So as we -- and just to get ahead of the question, if it comes out, we're obviously -- we didn't release anything on '22 in this call and aren't prepared to. I think like all of our peers in the industry, we're sitting here and trying to gauge what '22 looks like given this environment that we're in.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's right.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
When you say formal relationships, you mean with other media or what do you mean?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I would say Active WM is -- it's a mix. So it probably was a subtle comment, but now we have the full suite of solutions in the market. So Omni was a little more challenged, as you can imagine, in 2020, but we're seeing nice pickup there in the pipeline. MAWM, strong as well. We're seeing solid pipeline with TMS. So it's -- the pipeline has got good diversity to it.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Hi. Thanks for taking my questions. Brent, I was wondering if you could comment on the reception to and progress of the B2B business.
I know you announced that earlier this year. Maybe give us a sense of the level of urgency you're seeing from B2B organizations to up-level their own e-commerce efforts relative to B2C. Thanks.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
This backlog was -- it was varied, but there were some longer -- larger projects within this backlog that will take a bit more time as much as one to two years.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
You know, I think the -- I don't want to confuse or the PCR testing long-term with what's happening on the rapid point-of-care side. So there is still a fairly large amount of interest and contractual relationships being established between multiple different industries relative to their desire to continue to test, whether it's lab-based PCR or point-of-care or rapid testing. So, eventually, which -- I don't know when that will be, quite honestly. So I don't -- there's no plan yet to downsize any of the workforce relative to what's going on for COVID because of the huge demand that we're seeing on the point-of-care rapid side for multiple industries.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay. Yeah, what we've said is we're -- we've aligned the utility payout at 60% of EBS -- EPS and we'll grow in line with our earnings growth, and we believe that compares to other high-growth and high-quality utilities. We haven't made a determination on the capital allocation plan at SpinCo for some of the reasons that we've talked about in our prepared remarks. And the first and foremost, we're going to continue to pay down debt there to maintaining the strength of the balance sheet because we think that an investment grade rating is important. And then beyond that we'll determine how we return capital to the shareholders. And we expect to have those decisions made through time here, we're just not ready to commit to MAT at this point given some of the uncertainty.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Andrew. Great question. We've actually shifted our guidance methodology to the at least pre-pandemic. And I don't see us slipping back. I think you guys, as you alluded to, obviously, there's been a lot of uncertainty in the world. And we've been trying to since the beginning of the pandemic, plan thoughtfully, planned prudently. And even when we entered this year, I would say plan conservatively as well. As the world has stabilized and we've got a heck of a lot more visibility into how the business is performing. We are still comfortable with the guidance methodology that we have. That said, I'd reiterate what I said in my prepared remarks earlier around your expected variability. On that guidance moving forward, we would expect much less variability, probably more variability on the expense side than on the revenue side. But we are comfortable with the way that we guide now and the current methodology that we use.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Laurie, this is Paul. We might have to get back to you on some of those details. Arnold, do you have any color on that?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. This is Jason. So I think -- yes, I think -- so that's the -- that's our goal is trying to figure out how to monetize our environmental-proven performance in extremely low methane emissions. So that's the goal of -- from a sales perspective and an opportunity that's out there.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I think overall, we're always going to be very aware of what our competitors are doing in the back half, whether it's back-to-school or the holiday season. So we'll always be prepared to adjust as appropriately. We are very thoughtful about how we compete and where we compete in being thoughtful managers of the P&L, if you will.
But overall I would say the promotionality, we would say probably a little bit higher than what we experienced last year or fiscal '21, but still less promotional than we saw in fiscal '20 starting right now. Again, we'll look at that and manage it as it comes and as we see the holiday unfold a little bit, but -- because we will fundamentally always be competitive. But I think generally, we'll be more promotional than last year, probably less promotional than two years ago.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So last year we had -- first of all, the biggest customer of that facility is our Amphastar U.S., and we buy some APIs from them, and also we contract them to do some R&D work for us, mostly around the R&D of APIs. But last year we had over $3 million in sales, which was up significantly from the prior year, and I think what we said this year, was that we expect that number to double this year, and so, we should have more revenues this year. It wasn't reported in the press release, but we had a little over $1 million in third party sales from that facility in the first quarter this year. So it's already on a trend higher than the quarterly run rate from last year, and we do expect continued growth out of that facility.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. No, we -- I mean, we started gaining share in the fourth quarter of last year. And if I look at each one of the quarters, we've been gaining about a point, point and a half, two points of share. So I think we're back to being in a pretty good spot.
I mean there's always going to be elements of the different categories that we have. And certainly, for ORV, we feel good, for motorcycles, we feel really good, in boats, we feel great. So I think overall, we're in a good spot.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Marc, this is Andrew. The quick answer is everything that is what I would characterize as early development or research is not very much of our R&D spend. You could probably use Pareto assumptions to get to what I mean by that. And with respect to the commercial build-out, I mean, I'll take a stab at it and Frank Pasqualone can certainly correct me if I'm wrong. But we're looking -- and as we've talked about with investors for quite some time, we're looking with ampreloxetine, given that it's focused on a rare disease population, to build out our commercial infrastructure to rightsize the launch.
And of course, that will be based on finalizing the development time lines with the regulators once we have the study 169 results. And we will invest in the launch appropriately well in advance to ensure its success. But we will be leveraging existing investments that we're already making to support YUPELRI in the home office and in other areas of management and medical affairs. So the incremental investment to adequately support the launch of ampreloxetine will not be a material addition to our SG&A in total. But Frank?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, no. As you point out we've got plenty of capacity and I think you know as you look at what happened in the quarter, you know, kind of in a marginal way, you know, a little under $10 billion, we've increased the portfolio. So we've started to re -- redeploy a bit of it. But as you sort of point out, although the curve has steepened, you know, rates are still relatively low and so we're -- we're working to balance for the short-term carry we're gonna get, you know, by redeploying faster with, you know, OCI impacts over time and how to do this in the most effective way and -- and when we get good entry points where we're taking advantage of it.
So I would -- I would -- I would think that we're going to -- we're going to continue to redeploy at a -- at a -- at a prudent pace as we see opportunities that sort of makes sense from not just the, you know, short-term carry view but also all the other, you know, all the other items that we've sort of need to take into account as we sort of look forward.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I can't give you anything that isn't material and done yet, but what I would tell you this is a couple of things. Number one, Universal Music converted 10 million of net payables at $4.14 into equity. Right? Number two is all the record labels now, all the payables we picked up from Slacker are now paid off. Our balance sheet is now acceptable to everyone.
Right? We've had a weak balance sheet. We've done these acquisitions. We've done these partnerships, right, with a weak balance sheet. And all the record labels and publishers knew that When we bought Slacker.
Right? They knew going in and they accepted and they turned on light for us. Right? Now the lights are very different. Right? It's very different. The emotional, the financial relationship between [Inaudible] is very different.
And then as we publicly said for the first time, Elon personally approved the budget for all of connectivity in the car, right, through the end of this year. That's the first time we've ever seen that that has been done and approved, and we can talk about it. So I think there's huge opportunities, not only with Tesla, but across the board for us to expand. Right? And you may notice that we went from 73 cars, I think, to now 88 cars.
Right? You're going to continue to see that. And there's no reason to believe that in this year, we couldn't lend another car company as well as expanding with Tesla across the globe.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, thanks. On the expense side, is there anything for 2021, as we look out, that could bring just expense growth back down to sort of an inflation number? Or does the turnover and some of these other dynamics just step function this up for higher growth this year?

    Prediction (one of UP, DOWN, SAME): UP